Targeting Wnt Signaling in the Tumor Immune Microenvironment to Enhancing EpCAM CAR T-Cell therapy.

Li, Weizhen; Zhou, Yang; Wu, Zhongen; Shi, Yaoping; Tian, Enming; Zhu, Yingqi; Wang, Tao; Dou, Wei; Meng, Xiangjing; Chen, Ming; Zhai, Bo; Zhu, Di

Li, Weizhen; Zhou, Yang; Wu, Zhongen; Shi, Yaoping; Tian, Enming; Zhu, Yingqi; Wang, Tao; Dou, Wei; Meng, Xiangjing; Chen, Ming; Zhai, Bo; Zhu, Di.

Afiliação

Li W; Department of Laboratory Medicine, Sixth Affiliated Hospital of Yangzhou University, Taizhou, China.
Zhou Y; Department of Laboratory Medicine, Affiliated Taixing Hospital of Bengbu Medical College, Taizhou, China.
Wu Z; School of Pharmacy, Fudan University, Shanghai, China.
Shi Y; School of Pharmacy, Fudan University, Shanghai, China.
Tian E; Department of Interventional Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhu Y; School of Pharmacy, Fudan University, Shanghai, China.
Wang T; School of Pharmacy, Fudan University, Shanghai, China.
Dou W; Department of Interventional Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Meng X; Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Chen M; School of Pharmacy, Fudan University, Shanghai, China.
Zhai B; Shandong Academy of Pharmaceutical Science, Jinan, China.
Zhu D; Department of Laboratory Medicine, Sixth Affiliated Hospital of Yangzhou University, Taizhou, China.

Front Pharmacol ; 12: 724306, 2021.

Article em En | MEDLINE | ID: mdl-34790117

Palavras-chave

BCL9; EpCAM; Wnt signaling; chimeric antigen receptor T cells; tumor immune microenvironment

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google